AL

Alma Yesodot Ltd.

KVSR | TA

Overview

Corporate Details

ISIN(s):
IL0011731457
LEI:
Country:
Israel
Address:
HaBarzel 3, 6971005 Tel Aviv - Jaffa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kvasir focuses on developing innovative medical devices and diagnostic technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alma Yesodot Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-24 17:08
Regulatory News Service
Opening of Trading on April 27 2025-ALMA YESODOT B1
Hebrew (modern) 118.8 KB
2025-04-23 11:59
Regulatory News Service
Identifying Details of New Security-ALMA YESODOT B1
Hebrew (modern) 87.5 KB
2024-11-05 15:46
Regulatory News Service
Changes in the company's name and security, effective as of November 7, 2024
Hebrew (modern) 108.5 KB
2024-10-29 18:37
Regulatory News Service
The sector classification of the company will be changed, as of October 31, 202…
Hebrew (modern) 121.3 KB
2024-10-29 17:20
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2023-05-22 23:20
Report Publication Announcement
Frost and Sullivan is terminating coverage , following the completion of its co…
Hebrew (modern) 174.5 KB
2023-05-22 23:20
Pre-Annual General Meeting Information
Frost and Sullivan is terminating coverage , following the completion of its co…
Russian 46.0 KB
2023-03-23 21:00
Investor Presentation
Analysis update following financial report- price target is updated to NIS 22.7
English 1.2 MB
2023-03-23 21:00
Legal Proceedings Report
Analysis update following financial report- price target is updated to NIS 22.7
Russian 71.0 KB
2022-12-11 20:40
Investor Presentation
Analysis update following financial report- price target is updated to NIS 32.9…
English 1.2 MB
2022-12-11 20:40
Business and Financial Review
Analysis update following financial report- price target is updated to NIS 32.9…
Russian 67.3 KB
2022-08-30 20:47
Investor Presentation
Analysis update report ,target price is at 47.6NIS
English 1.2 MB
2022-08-30 20:47
Business and Financial Review
Analysis update report ,target price is at 47.6NIS
Russian 63.9 KB
2022-08-18 16:58
Investor Presentation
Presentation
English 3.0 MB
2022-08-18 16:58
Pre-Annual General Meeting Information
Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Alma Yesodot Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alma Yesodot Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea 206650

Talk to a Data Expert

Have a question? We'll get back to you promptly.